SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway.

Authors:
Sun L; Liu L; Liang D; Liu L.

Journal:
BMC Pulm Med

Publication Year: 2024

DOI:
10.1186/s12890-024-02857-6

PMCID:
PMC10809471

PMID:
38267898

Journal Information

Full Title: BMC Pulm Med

Abbreviation: BMC Pulm Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was conducted in accordance with the Guideline for the Care and Use of Laboratory Animals from National Institutes of Health (NIH) and ARRIVE. All experiments were undertaken with approval of the Animal Ethics Committee of Jinzhou Medical University. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was funded by the Natural Science Foundation of Liaoning Province (2023-MS-305)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025